{"product_id":"glp3-20mg","title":"GIP\/GLP-1\/GCGR Tri-Agonist- 20mg","description":"\u003ch2\u003e\u003cstrong\u003e\u003cspan\u003eGIP\/GLP-1\/GCGR Tri-Agonist\u003c\/span\u003e– 20 mg\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eResearch Use Only \/ Not for Human or Veterinary Use\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cstrong\u003e\u003cstrong\u003eCAS No. 2381089-83-2\u003c\/strong\u003e\u003c\/strong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGIP\/GLP-1\/GCGR Tri-Agonist is a synthetic peptide compound characterized by a defined molecular structure and described in scientific and biochemical literature. This material is supplied \u003cstrong\u003eexclusively for controlled laboratory research and analytical reference purposes\u003c\/strong\u003e and is \u003cstrong\u003enot intended for clinical, therapeutic, consumer, or pharmaceutical use\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eThis 20 mg vial of GIP\/GLP-1\/GCGR Tri-Agonist is provided as a \u003cstrong\u003echemically characterized, lyophilized compound\u003c\/strong\u003e, manufactured to internal research specifications and sealed to preserve \u003cstrong\u003echemical integrity during storage and handling\u003c\/strong\u003e. The 20 mg format supports analytical reference work, comparative compound evaluation, and other \u003cstrong\u003enon-clinical laboratory research applications\u003c\/strong\u003e requiring extended material availability.\u003c\/p\u003e\n\u003cp\u003eThis product is offered \u003cstrong\u003estrictly for laboratory research and analytical use only\u003c\/strong\u003e and is \u003cstrong\u003enot intended for human or animal consumption, administration, or exposure\u003c\/strong\u003e.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003e\u003cstrong\u003eTechnical Information\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eChemical Description: GIP\/GLP-1\/GCGR Tri-Agonist (synthetic peptide compound)\u003c\/p\u003e\n\u003cp\u003eAmino Acid Sequence: Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-α-Me-Leu-Leu-Asp-Lys-(modified)-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂\u003c\/p\u003e\n\u003cp\u003eMolecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈\u003c\/p\u003e\n\u003cp\u003eMolecular Weight: 4731.33 g\/mol\u003c\/p\u003e\n\u003cp\u003ePurity: ≥99% (chemical purity)\u003c\/p\u003e\n\u003cp\u003eForm: Solid, lyophilized powder\u003c\/p\u003e\n\u003cp\u003eCertificate of Analysis (CoA): Available upon request\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003e\u003cstrong\u003eAnalytical Scope \u0026amp; Limitations\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eAnalytical characterization of this material is limited to \u003cstrong\u003echemical identity, structure, and purity testing only\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNo sterility, endotoxin, bioburden, toxicology, pharmacokinetic, metabolic, endocrine activity, immunogenicity, or clinical safety studies have been performed.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAs a result, \u003cstrong\u003ehuman or animal exposure presents unknown and potentially serious risks\u003c\/strong\u003e.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003e\u003cstrong\u003eQuality \u0026amp; Standards\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eAt \u003cstrong\u003eAltera Peptides Inc.\u003c\/strong\u003e, products are sourced and handled with an emphasis on quality control, traceability, and reproducibility for \u003cstrong\u003eresearch applications only\u003c\/strong\u003e. Internal standards are designed to support \u003cstrong\u003eanalytical consistency\u003c\/strong\u003e, not pharmaceutical, clinical, or therapeutic use.\u003c\/p\u003e\n\u003cp\u003eOur commitment includes:\u003c\/p\u003e\n\u003cp\u003eControlled compound synthesis and handling processes\u003c\/p\u003e\n\u003cp\u003eBatch consistency standards\u003c\/p\u003e\n\u003cp\u003eClear labeling and compliance practices\u003c\/p\u003e\n\u003cp\u003eSecure packaging to maintain product integrity\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003e\u003cstrong\u003eIntended Use \u0026amp; Compliance\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eThis product is provided \u003cstrong\u003estrictly for laboratory research and analytical purposes only\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNot for use as:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA drug or pharmaceutical product\u003c\/p\u003e\n\u003cp\u003eA dietary supplement\u003c\/p\u003e\n\u003cp\u003eA cosmetic\u003c\/p\u003e\n\u003cp\u003eA diagnostic, therapeutic, or clinical material\u003c\/p\u003e\n\u003cp\u003eThis product is \u003cstrong\u003enot manufactured in compliance with Good Manufacturing Practice (GMP) requirements for human use\u003c\/strong\u003e and has \u003cstrong\u003enot been approved, reviewed, or authorized by the FDA, Health Canada, EMA, or any other regulatory authority\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eBy purchasing this product, the buyer acknowledges and agrees that it is intended \u003cstrong\u003esolely for non-medical, non-clinical research use by qualified personnel in appropriate laboratory environments\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cdiv style=\"text-align: center;\" align=\"center\" class=\"MsoNormal\"\u003e\u003chr align=\"center\" width=\"100%\" size=\"2\"\u003e\u003c\/div\u003e","brand":"Altera Peptides Inc.","offers":[{"title":"Default Title","offer_id":51762560434455,"sku":null,"price":150.0,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0974\/5373\/6215\/files\/AlteraPeptides-GIP_GLP-1_GCGR_Tri-Agonist-20mg.png?v=1786972349","url":"https:\/\/www.alterapeptidesinc.com\/products\/glp3-20mg","provider":"Altera Peptides Inc.","version":"1.0","type":"link"}